1. Author response. Issue 12 (4th October 2018) Authors: Stoll, Felicitas; Gödde, Miriel; Leo, Albrecht; Katus, Hugo A.; Müller, Oliver J. Journal: Clinical cardiology Issue: Volume 41:Issue 12(2018) Page Start: 1528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of hospitalized cardiovascular patients with suspected heparin‐induced thrombocytopenia. Issue 12 (3rd December 2018) Authors: Stoll, Felicitas; Gödde, Miriel; Leo, Albrecht; Katus, Hugo A.; Müller, Oliver J. Journal: Clinical cardiology Issue: Volume 41:Issue 12(2018) Page Start: 1521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug‐Drug Interaction Trial in Healthy Adults. Issue 2 (15th July 2021) Authors: Stoll, Felicitas; Blank, Antje; Mikus, Gerd; Czock, David; Foerster, Kathrin I.; Hermann, Simon; Gümüs, Katja; Muhareb, Amin; Hummler, Simone; Sauter, Max; Weiss, Johanna; Burhenne, Jürgen; Haefeli, Walter E. Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 2(2022) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers. Issue 10 (23rd July 2022) Authors: Blank, Antje; Hohmann, Nicolas; Dettmer, Marlen; Manka‐Stuhlik, Anette; Mikus, Gerd; Stoll, Felicitas; Stützle‐Schnetz, Marlies; Thomas, Daniel; Exner, Evelyn; Schmitt‐Bormann, Beate; Schaller, Torsten; Laage, Rico; Schönborn‐Kellenberger, Oliver; Arndt, Michaela; Haefeli, Walter E.; Krauss, Jürgen Journal: Clinical and translational science Issue: Volume 15:Issue 10(2022) Page Start: 2366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activity. (31st August 2013) Authors: Stoll, Felicitas; Burhenne, Jürgen; Lausecker, Berthold; Weiss, Johanna; Thomsen, Torben; Haefeli, Walter Emil; Mikus, Gerd Journal: Journal of clinical pharmacology Issue: Volume 53:Number 11(2013:Nov.) Page Start: 1199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗